VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2019 | New promise in treating mBC: combining anti-AR therapy with chemotherapy

Here, Shilpa Gupta, MD, of the University of Minnesota, Minneapolis, MN, presents promising results from a Phase I trial (NCT02300610) investigating the combined use of enzalutamide with gemcitabine and cisplatin in metastatic bladder cancer (mBC). This video was taken at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter